Categories AlphaGraphs, Earnings, Health Care
A visual representation of Trxade Group (MEDS) Q1 2020 earnings
Trxade Group Inc. (NASDAQ: MEDS) reported its financial results for the quarter ended March 31, 2020, on Monday, May 4, before the market opens. The bottom-line soared by 44% as platform sales drove the top-line higher by 46%.
The company continued to expand its trading platform organically, with 305 new independent pharmacies registered in Q1 2020. The average purchases per pharmacy increased on the Trxade platform by 13.7% in the first quarter of 2020, when compared to the same year-ago quarter.
During Q1, the company took strategic measures to enhance its corporate position, uplisting its common stock to the Nasdaq Capital Market and engaging an investor relations firm to implement a comprehensive capital markets strategy.
Take a look at our Health Care articles here
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
